In contrast, although m-alloknesis associated with AD was not suppressed by the JAK2 inhibitor (AZ960), it was significantly suppressed by the JAK1 inhibitor (Abrocitinib) and JAK1/2 inhibitor (Baricitinib) (Figure 4b). Here, JAK1 is linked to Alzheimer disease.